Oxford Tech 3 VCT Oxford Technology 3 Vct Plc : Interim Management Statement
December 19 2013 - 5:35AM
UK Regulatory
TIDMOTT
Oxford Technology 3 VCT PLC
Interim Management Statement
For the six months commencing 1 September 2013
Oxford Technology 3 VCT PLC presents its interim management statement
for the period commencing 1 September 2013, as required by the UK
Listing Authority's Disclosure and Transparency Rule 4.3
The Directors reviewed the valuation of its entire portfolio at a Board
meeting on 5December 2013.
The unaudited net asset value per ordinary share as at 30 November 2013
was 93p. This is a fall of 7p per share from the last quarter ending 31
August 2013. This is mainly due to a fall in the price of shares in
Scancell Plc, which is quoted on AIM.
The total number of ordinary shares in issue is 6,785,233.
During the quarter, a follow on investment in Polytherics (GBP53k) was
made. There were no disposals.
Since 30 November 2013, the price of shares in Scancell has risen
following a successful round of medical trials. Due to this, as at 19
December 2013, the unaudited net asset value per ordinary share would be
98p per share. This is a rise of 5p per share from 30 November 2013.
The Directors are not aware of any other events or transactions which
have taken place between 31 August 2013 and the publication of this
statement which have had a material effect on the financial position of
the Company.
19 December 2013
Enquiries:
Lucius Cary, Oxford Technology Management
01865 784466
This announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the information
contained therein.
Source: Oxford Technology 3 VCT plc via Globenewswire
HUG#1751164
http://www.oxfordtechnology.com
Oxford Technology 3 Vent... (LSE:OTT)
Historical Stock Chart
From Sep 2024 to Oct 2024
Oxford Technology 3 Vent... (LSE:OTT)
Historical Stock Chart
From Oct 2023 to Oct 2024